Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: A prospective multicenter trial

Asaf Senft; Remco de Bree; Otto S. Hoekstra; Dirk J. Kuik; Richard P. Golding; Wim J.G. Oyen; Jan Pruim; Frank J. van den Hoogen; Jan L.N. Roodenburg; C. René Leemans

doi:10.1016/j.radonc.2008.03.008

Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: A prospective multicenter trial

Asaf Senft, Remco de Bree^*, Otto S. Hoekstra, Dirk J. Kuik, Richard P. Golding, Wim J.G. Oyen, Jan Pruim, Frank J. van den Hoogen, Jan L.N. Roodenburg, C. René Leemans

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

78 Citations (Scopus)

Abstract

Background and purpose: The aim of the study was to define the added value of whole body FDG-PET in screening for distant metastases in patients with head and neck squamous cell carcinoma and risk factors. Materials and methods: In a multi-center prospective study between 1998 and 2003, 145 consecutive HNSCC patients with risk factors for distant metastases underwent chest CT and whole body FDG-PET for screening of distant metastases. The data of 92 evaluable patients who developed distant metastases or who had a follow-up of at least 12 months were analyzed. Besides their performance in clinical practice, the operational characteristics of PET and CT using ROC analyses were investigated. Results: Pretreatment screening identified distant metastases in 19 patients (21%). FDG-PET had a higher sensitivity (53% vs. 37%) and positive predictive value (80% vs. 75%) than CT. The combination of CT and FDG-PET had the highest sensitivity (63%). The ROC analyses of the five point ordinal scales revealed that the "area under the curve" (AUC) of FDG-PET was significantly higher as compared to CT. Conclusion: In HNSCC patients with risk factors, pretreatment screening for distant metastases by chest CT is improved by FDG-PET.

Original language	English
Pages (from-to)	221-229
Number of pages	9
Journal	Radiotherapy and Oncology
Volume	87
Issue number	2
DOIs	https://doi.org/10.1016/j.radonc.2008.03.008
Publication status	Published - 1 May 2008

Keywords

CT
Distant metastases
FDG-PET
Head and neck cancer
Screening

Access to Document

10.1016/j.radonc.2008.03.008

Cite this

Senft, A., de Bree, R., Hoekstra, O. S., Kuik, D. J., Golding, R. P., Oyen, W. J. G., Pruim, J., van den Hoogen, F. J., Roodenburg, J. L. N., & Leemans, C. R. (2008). Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: A prospective multicenter trial. Radiotherapy and Oncology, 87(2), 221-229. https://doi.org/10.1016/j.radonc.2008.03.008

@article{62a15427dee94109ad7400bb97d584cb,

title = "Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: A prospective multicenter trial",

abstract = "Background and purpose: The aim of the study was to define the added value of whole body FDG-PET in screening for distant metastases in patients with head and neck squamous cell carcinoma and risk factors. Materials and methods: In a multi-center prospective study between 1998 and 2003, 145 consecutive HNSCC patients with risk factors for distant metastases underwent chest CT and whole body FDG-PET for screening of distant metastases. The data of 92 evaluable patients who developed distant metastases or who had a follow-up of at least 12 months were analyzed. Besides their performance in clinical practice, the operational characteristics of PET and CT using ROC analyses were investigated. Results: Pretreatment screening identified distant metastases in 19 patients (21%). FDG-PET had a higher sensitivity (53% vs. 37%) and positive predictive value (80% vs. 75%) than CT. The combination of CT and FDG-PET had the highest sensitivity (63%). The ROC analyses of the five point ordinal scales revealed that the {"}area under the curve{"} (AUC) of FDG-PET was significantly higher as compared to CT. Conclusion: In HNSCC patients with risk factors, pretreatment screening for distant metastases by chest CT is improved by FDG-PET.",

keywords = "CT, Distant metastases, FDG-PET, Head and neck cancer, Screening",

author = "Asaf Senft and {de Bree}, Remco and Hoekstra, {Otto S.} and Kuik, {Dirk J.} and Golding, {Richard P.} and Oyen, {Wim J.G.} and Jan Pruim and {van den Hoogen}, {Frank J.} and Roodenburg, {Jan L.N.} and Leemans, {C. Ren{\'e}}",

year = "2008",

month = may,

day = "1",

doi = "10.1016/j.radonc.2008.03.008",

language = "English",

volume = "87",

pages = "221--229",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

Senft, A, de Bree, R, Hoekstra, OS, Kuik, DJ, Golding, RP, Oyen, WJG, Pruim, J, van den Hoogen, FJ, Roodenburg, JLN & Leemans, CR 2008, 'Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: A prospective multicenter trial', Radiotherapy and Oncology, vol. 87, no. 2, pp. 221-229. https://doi.org/10.1016/j.radonc.2008.03.008

TY - JOUR

T1 - Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET

T2 - A prospective multicenter trial

AU - Senft, Asaf

AU - de Bree, Remco

AU - Hoekstra, Otto S.

AU - Kuik, Dirk J.

AU - Golding, Richard P.

AU - Oyen, Wim J.G.

AU - Pruim, Jan

AU - van den Hoogen, Frank J.

AU - Roodenburg, Jan L.N.

AU - Leemans, C. René

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Background and purpose: The aim of the study was to define the added value of whole body FDG-PET in screening for distant metastases in patients with head and neck squamous cell carcinoma and risk factors. Materials and methods: In a multi-center prospective study between 1998 and 2003, 145 consecutive HNSCC patients with risk factors for distant metastases underwent chest CT and whole body FDG-PET for screening of distant metastases. The data of 92 evaluable patients who developed distant metastases or who had a follow-up of at least 12 months were analyzed. Besides their performance in clinical practice, the operational characteristics of PET and CT using ROC analyses were investigated. Results: Pretreatment screening identified distant metastases in 19 patients (21%). FDG-PET had a higher sensitivity (53% vs. 37%) and positive predictive value (80% vs. 75%) than CT. The combination of CT and FDG-PET had the highest sensitivity (63%). The ROC analyses of the five point ordinal scales revealed that the "area under the curve" (AUC) of FDG-PET was significantly higher as compared to CT. Conclusion: In HNSCC patients with risk factors, pretreatment screening for distant metastases by chest CT is improved by FDG-PET.

AB - Background and purpose: The aim of the study was to define the added value of whole body FDG-PET in screening for distant metastases in patients with head and neck squamous cell carcinoma and risk factors. Materials and methods: In a multi-center prospective study between 1998 and 2003, 145 consecutive HNSCC patients with risk factors for distant metastases underwent chest CT and whole body FDG-PET for screening of distant metastases. The data of 92 evaluable patients who developed distant metastases or who had a follow-up of at least 12 months were analyzed. Besides their performance in clinical practice, the operational characteristics of PET and CT using ROC analyses were investigated. Results: Pretreatment screening identified distant metastases in 19 patients (21%). FDG-PET had a higher sensitivity (53% vs. 37%) and positive predictive value (80% vs. 75%) than CT. The combination of CT and FDG-PET had the highest sensitivity (63%). The ROC analyses of the five point ordinal scales revealed that the "area under the curve" (AUC) of FDG-PET was significantly higher as compared to CT. Conclusion: In HNSCC patients with risk factors, pretreatment screening for distant metastases by chest CT is improved by FDG-PET.

KW - CT

KW - Distant metastases

KW - FDG-PET

KW - Head and neck cancer

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=43049176665&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2008.03.008

DO - 10.1016/j.radonc.2008.03.008

M3 - Article

C2 - 18410977

AN - SCOPUS:43049176665

SN - 0167-8140

VL - 87

SP - 221

EP - 229

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

IS - 2

ER -

Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: A prospective multicenter trial

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this